The weight management company is pivoting to become a telehealth service provider, enabling users to obtain prescriptions for medications such as Ozempic, Wegovy, and Trulicity.
NEW YORK — WeightWatchers announced on Tuesday that it is seeking Chapter 11 bankruptcy protection to discharge $1.15 billion of its debt, allowing it to concentrate on evolving into a telehealth service provider.
The parent company, WW International Inc., stated that almost 75% of its debt holders are in agreement. It anticipates emerging from bankruptcy in no more than 45 days, potentially even sooner.
WeightWatchers, which was founded more than 60 years ago, has struggled recently. In 2023, the company moved into the prescription drug weight loss business — particularly with the $106 million acquisition of Sequence, now WeightWatchers Clinic, a telehealth service that helps users get prescriptions for drugs like Ozempic, Wegovy and Trulicity.
Its latest earnings report Tuesday showed that first-quarter revenue declined 10% while its loss on an adjusted basis totaled 47 cents per share. However, clinical subscription revenue — or weight-loss medications — jumped 57% year over year to $29.5 million.
In September, WW International CEO Sima Sistani resigned, and the New York company named Tara Comonte, a WeightWatchers board member and former Shake Shack executive, interim chief executive.
Comonte, now CEO, said in a statement Tuesday that, “As the conversation around weight shifts toward long-term health, our commitment to delivering the most trusted, science-backed, and holistic solutions —grounded in community support and lasting results — has never been stronger, or more important.”
Shares of the company have traded at under $1 since early February. In after-hours trading, the stock plunged by half to 39 cents.
The bankruptcy filing was made in U.S. Bankruptcy Court for the District of Delaware.
Copyright 2025 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
